{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:53:23Z","timestamp":1762955603241},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T00:00:00Z","timestamp":1466208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11886-016-0752-7","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T06:31:00Z","timestamp":1466231460000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis"],"prefix":"10.1007","volume":"18","author":[{"given":"James A.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nowell M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,18]]},"reference":[{"key":"752_CR1","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","volume":"1","author":"SM Banypersad","year":"2012","unstructured":"Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc. 2012;1:e000364.","journal-title":"J Am Heart Assoc"},{"key":"752_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","volume":"91","author":"SW Dubrey","year":"1998","unstructured":"Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998;91:141\u201357.","journal-title":"QJM"},{"key":"752_CR3","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1161\/CIRCULATIONAHA.111.069195","volume":"126","author":"CC Quarta","year":"2012","unstructured":"Quarta CC, Kruger JL, Falk RH. Cardiac amyloidosis. Circulation. 2012;126:e178\u201382.","journal-title":"Circulation"},{"key":"752_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","volume":"372","author":"CC Quarta","year":"2015","unstructured":"Quarta CC, Buxbaum JN, Shah AM, et al. The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015;372:21\u20139.","journal-title":"N Engl J Med"},{"key":"752_CR5","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonzalez-Lopez","year":"2015","unstructured":"Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36:2585\u201394. An important study identifying a high (13%) estimated prevalence of wild-type thransthyretin amyloidosis as an underlying cause of heart failure with preserved ejection fraction.","journal-title":"Eur Heart J"},{"key":"752_CR6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012;30:989\u201395.","journal-title":"J Clin Oncol"},{"key":"752_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1751-7133.2012.00303.x","volume":"18","author":"A Castano","year":"2012","unstructured":"Castano A, Helmke S, Alvarez J, Delisle S, Maurer MS. Diflunisal for ATTR cardiac amyloidosis. Congest Heart Fail. 2012;18:315\u20139.","journal-title":"Congest Heart Fail"},{"key":"752_CR8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12265-013-9512-x","volume":"6","author":"G Merlini","year":"2013","unstructured":"Merlini G, Plante-Bordeneuve V, Judge DP, et al. Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis. J Cardiovasc Transl Res. 2013;6:1011\u201320.","journal-title":"J Cardiovasc Transl Res"},{"key":"752_CR9","doi-asserted-by":"crossref","first-page":"97ra81","DOI":"10.1126\/scitranslmed.3002473","volume":"3","author":"MM Alhamadsheh","year":"2011","unstructured":"Alhamadsheh MM, Connelly S, Cho A, et al. Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity. Sci Transl Med. 2011;3:97ra81.","journal-title":"Sci Transl Med"},{"key":"752_CR10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","volume":"369","author":"T Coelho","year":"2013","unstructured":"Coelho T, Adams D, Silva A, et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med. 2013;369:819\u201329.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"752_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/13506129.2011.574354021","volume":"18","author":"MD Benson","year":"2011","unstructured":"Benson MD, Pandey S, Witchell D, et al. Antisense oligonucleotide therapy for TTR amyloidosis. Amyloid. 2011;18 Suppl 1:60.","journal-title":"Amyloid"},{"key":"752_CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1096\/fj.05-4509com","volume":"20","author":"I Cardoso","year":"2006","unstructured":"Cardoso I, Saraiva MJ. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model. FASEB J. 2006;20:234\u20139.","journal-title":"FASEB J"},{"key":"752_CR13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","volume":"417","author":"MB Pepys","year":"2002","unstructured":"Pepys MB, Herbert J, Hutchinson WL, et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature. 2002;417:254\u20139.","journal-title":"Nature"},{"key":"752_CR14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","volume":"7","author":"RH Falk","year":"2014","unstructured":"Falk RH, Quarta CC, Dorbala S. How to image cardiac amyloidosis. Circ Cardiovasc Imaging. 2014;7:552\u201362.","journal-title":"Circ Cardiovasc Imaging"},{"key":"752_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","volume":"20","author":"C Rapezzi","year":"2015","unstructured":"Rapezzi C, Lorenzini M, Longhi S, et al. Cardiac amyloidosis: the great pretender. Heart Fail Rev. 2015;20:117\u201324.","journal-title":"Heart Fail Rev"},{"key":"752_CR16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","volume":"133","author":"LH Connors","year":"2016","unstructured":"Connors LH, Sam F, Skinner M, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study. Circulation. 2016;133:282\u201390. A study identifying the poor prognosis of patients with wild-type thransthyretin amyloidosis, clarifying relevance for its detection in the management of heart failure patients.","journal-title":"Circulation"},{"key":"752_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","volume":"22","author":"A Tendler","year":"2015","unstructured":"Tendler A, Helmke S, Teruya S, Alvarez J, Maurer MS. The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis. Amyloid. 2015;22:61\u20136.","journal-title":"Amyloid"},{"key":"752_CR18","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","volume":"107","author":"J Koyama","year":"2003","unstructured":"Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107:2446\u201352.","journal-title":"Circulation"},{"key":"752_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.echo.2003.09.014","volume":"17","author":"J Koyama","year":"2004","unstructured":"Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr. 2004;17:36\u201344.","journal-title":"J Am Soc Echocardiogr"},{"key":"752_CR20","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","volume":"129","author":"CC Quarta","year":"2014","unstructured":"Quarta CC, Solomon SD, Uraizee I, et al. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation. 2014;129:1840\u20139.","journal-title":"Circulation"},{"key":"752_CR21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","volume":"15","author":"G Bella Di","year":"2014","unstructured":"Di Bella G, Pizzino F, Minutoli F, et al. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. Eur Heart J Cardiovasc Imaging. 2014;15:1307\u201315.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"752_CR22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.CIR.83.3.808","volume":"83","author":"AL Klein","year":"1991","unstructured":"Klein AL, Hatle LK, Taliercio CP, et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation. 1991;83:808\u201316.","journal-title":"Circulation"},{"key":"752_CR23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009;120:1203\u201312.","journal-title":"Circulation"},{"key":"752_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2011.01.015","volume":"24","author":"V Mor-Avi","year":"2011","unstructured":"Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr. 2011;24:277\u2013313.","journal-title":"J Am Soc Echocardiogr"},{"key":"752_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13506120902879681","volume":"16","author":"MC Porciani","year":"2009","unstructured":"Porciani MC, Lilli A, Perfetto F, et al. Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid. 2009;16:63\u201370.","journal-title":"Amyloid"},{"key":"752_CR26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.euje.2005.03.004","volume":"7","author":"P Lindqvist","year":"2006","unstructured":"Lindqvist P, Olofsson BO, Backman C, Suhr O, Waldenstrom A. Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr. 2006;7:22\u201330.","journal-title":"Eur J Echocardiogr"},{"key":"752_CR27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.amjcard.2007.11.047","volume":"101","author":"D Bellavia","year":"2008","unstructured":"Bellavia D, Pellikka PA, Abraham TP, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol. 2008;101:1039\u201345.","journal-title":"Am J Cardiol"},{"key":"752_CR28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.amjcard.2008.09.102","volume":"103","author":"JP Sun","year":"2009","unstructured":"Sun JP, Stewart WJ, Yang XS, et al. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol. 2009;103:411\u20135.","journal-title":"Am J Cardiol"},{"key":"752_CR29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1253\/circj.CJ-10-0844","volume":"75","author":"G Bella Di","year":"2011","unstructured":"Di Bella G, Minutoli F, Pingitore A, et al. Endocardial and epicardial deformations in cardiac amyloidosis and hypertrophic cardiomyopathy. Circ J. 2011;75:1200\u20138.","journal-title":"Circ J"},{"key":"752_CR30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCIMAGING.113.000683","volume":"6","author":"D Liu","year":"2013","unstructured":"Liu D, Hu K, Niemann M, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013;6:1066\u201372.","journal-title":"Circ Cardiovasc Imaging"},{"key":"752_CR31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","volume":"21","author":"WA Aljaroudi","year":"2014","unstructured":"Aljaroudi WA, Desai MY, Tang WH, Phelan D, Cerqueira MD, Jaber WA. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques. J Nucl Cardiol. 2014;21:271\u201383.","journal-title":"J Nucl Cardiol"},{"key":"752_CR32","first-page":"159","volume":"31","author":"F Cappelli","year":"2011","unstructured":"Cappelli F, Porciani MC, Bergesio F, et al. Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. Clin Physiol Funct Imaging. 2011;31:159\u201365.","journal-title":"Clin Physiol Funct Imaging"},{"key":"752_CR33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1540-8175.2012.01680.x","volume":"29","author":"H Baccouche","year":"2012","unstructured":"Baccouche H, Maunz M, Beck T, et al. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography. 2012;29:668\u201377.","journal-title":"Echocardiography"},{"key":"752_CR34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1540-8175.2010.01344.x","volume":"28","author":"C Engvall","year":"2011","unstructured":"Engvall C, Henein M, Holmgren A, Suhr OB, Morner S, Lindqvist P. Can myocardial strain differentiate hypertrophic from infiltrative etiology of a thickened septum? Echocardiography. 2011;28:408\u201315.","journal-title":"Echocardiography"},{"key":"752_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/eurheartj\/ehi040","volume":"26","author":"KM Modesto","year":"2005","unstructured":"Modesto KM, Dispenzieri A, Cauduro SA, et al. Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J. 2005;26:173\u20139.","journal-title":"Eur Heart J"},{"key":"752_CR36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9149(97)00400-1","volume":"80","author":"AR Patel","year":"1997","unstructured":"Patel AR, Dubrey SW, Mendes LA, et al. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol. 1997;80:486\u201392.","journal-title":"Am J Cardiol"},{"key":"752_CR37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejheart.2007.05.006","volume":"9","author":"S Ghio","year":"2007","unstructured":"Ghio S, Perlini S, Palladini G, et al. Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail. 2007;9:808\u201313.","journal-title":"Eur J Heart Fail"},{"key":"752_CR38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ejechocard\/jer289","volume":"13","author":"F Cappelli","year":"2012","unstructured":"Cappelli F, Porciani MC, Bergesio F, et al. Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging. 2012;13:416\u201322.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"752_CR39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jmri.23756","volume":"37","author":"RM Simpson","year":"2013","unstructured":"Simpson RM, Keegan J, Firmin DN. MR assessment of regional myocardial mechanics. J Magn Reson Imaging. 2013;37:576\u201399.","journal-title":"J Magn Reson Imaging"},{"key":"752_CR40","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","volume":"8","author":"P Claus","year":"2015","unstructured":"Claus P, Omar AM, Pedrizzetti G, Sengupta PP, Nagel E. Tissue tracking technology for assessing cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging. 2015;8:1444\u201360.","journal-title":"JACC Cardiovasc Imaging"},{"key":"752_CR41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","volume":"36","author":"SM Banypersad","year":"2015","unstructured":"Banypersad SM, Fontana M, Maestrini V, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015;36:244\u201351. A study highlighting the role of the MRI-based technique called T1 mapping to identify patients with cardiac amyloidosis.","journal-title":"Eur Heart J"},{"key":"752_CR42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","volume":"7","author":"M Fontana","year":"2014","unstructured":"Fontana M, Banypersad SM, Treibel TA, et al. Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging. 2014;7:157\u201365.","journal-title":"JACC Cardiovasc Imaging"},{"key":"752_CR43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6:488\u201397.","journal-title":"JACC Cardiovasc Imaging"},{"key":"752_CR44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","volume":"7","author":"JN Dungu","year":"2014","unstructured":"Dungu JN, Valencia O, Pinney JH, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:133\u201342.","journal-title":"JACC Cardiovasc Imaging"},{"key":"752_CR45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186\u201393.","journal-title":"Circulation"},{"key":"752_CR46","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132:1570\u20139. A study describing the capacity of routine cardiac MRI with late gadolinium enhancement to identify and provide prognostic information in patients suspected of cardiac amyloidosis.","journal-title":"Circulation"},{"key":"752_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","volume":"7","author":"JA White","year":"2014","unstructured":"White JA, Kim HW, Shah D, et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:143\u201356.","journal-title":"JACC Cardiovasc Imaging"},{"key":"752_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","volume":"6","author":"SM Banypersad","year":"2013","unstructured":"Banypersad SM, Sado DM, Flett AS, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circulation Cardiovascular imaging. 2013;6:34\u20139.","journal-title":"Circulation Cardiovascular imaging"},{"key":"752_CR49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","volume":"277","author":"M Fontana","year":"2015","unstructured":"Fontana M, Banypersad SM, Treibel TA, et al. Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study. Radiology. 2015;277:388\u201397.","journal-title":"Radiology"},{"key":"752_CR50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jcct.2015.07.001","volume":"9","author":"TA Treibel","year":"2015","unstructured":"Treibel TA, Bandula S, Fontana M, et al. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr. 2015;9:585\u201392.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"752_CR51","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12149-012-0627-y","volume":"26","author":"Y Yamamoto","year":"2012","unstructured":"Yamamoto Y, Onoguchi M, Haramoto M, et al. Novel method for quantitative evaluation of cardiac amyloidosis using (201)TlCl and (99m)Tc-PYP SPECT. Ann Nucl Med. 2012;26:634\u201343.","journal-title":"Ann Nucl Med"},{"key":"752_CR52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","volume":"6","author":"S Bokhari","year":"2013","unstructured":"Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195\u2013201.","journal-title":"Circ Cardiovasc Imaging"},{"key":"752_CR53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4:659\u201370.","journal-title":"JACC Cardiovasc Imaging"},{"key":"752_CR54","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00259-012-2187-8","volume":"39","author":"W Noordzij","year":"2012","unstructured":"Noordzij W, Glaudemans AW, van Rheenen RW, et al. (123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis. Eur J Nucl Med Mol Imaging. 2012;39:1609\u201317.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"752_CR55","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MC Coutinho","year":"2013","unstructured":"Coutinho MC, Cortez-Dias N, Cantinho G, et al. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging. 2013;6:627\u201336.","journal-title":"Circ Cardiovasc Imaging"},{"key":"752_CR56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","volume":"54","author":"G Antoni","year":"2013","unstructured":"Antoni G, Lubberink M, Estrada S, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med. 2013;54:213\u201320.","journal-title":"J Nucl Med"},{"key":"752_CR57","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Semer J, et al. Imaging cardiac amyloidosis: a pilot study using (1)(8)F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41:1652\u201362.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0752-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-016-0752-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0752-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T22:39:14Z","timestamp":1568068754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-016-0752-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,18]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1007\/s11886-016-0752-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,18]]},"article-number":"77"}}